The prognostic value of elevated matrix metalloproteinase-9 in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: A two-year prospective study
Introduction: Increased matrix metalloproteinase-9 (MMP-9) levels in ST-elevation myocardial infarction (STEMI) are well established; however, existing data on MMP-9 values as a prognostic marker after STEMI are limited and have been conflicting. Objective: This study aimed to assess the clinical si...
Egile Nagusiak: | , , , , , , , , |
---|---|
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
Elsevier
2020-05-01
|
Saila: | Revista Portuguesa de Cardiologia |
Gaiak: | |
Sarrera elektronikoa: | http://www.sciencedirect.com/science/article/pii/S0870255120302079 |